首页> 外文OA文献 >OP0023 Four-year imaging outcomes in axial spondyloarthritis patients treated with certolizumab pegol, including patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

【2h】

OP0023 Four-year imaging outcomes in axial spondyloarthritis patients treated with certolizumab pegol, including patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

机译：OP0023轴向脊柱间关节炎患者的四年成像结果，用Certolizumab Pegol治疗，包括带状肌脊柱炎和非射线照相轴向脊髓灰质炎的患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
D van der Heijde; X Baraliakos; KG Hermann; R Landewé; PM Machado; W Maksymowych; O Davies; N de Peyrecave; B Hoepken; L Bauer; T Nurminen; J Braun;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CERTOLIZUMAB PEGOL IS ASSOCIATED WITH LONG-TERM IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-AXSPA STUDY [J] . Sieper J., Kivitz A., van Tubergen A., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：CERTOLIZUMAB PEGOL与轴突性关节炎患者的患者报告结果的长期改善相关，包括强直性脊柱炎和非放射性轴突性脊椎关节炎：4年的研究成果
2. LONG-TERM IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION OVER 4 YEARS OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS [J] . van der Heijde D., Braun J., Rudwaleit M., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：轴突性关节炎患者4年来西妥珠单抗治疗的工作场所，家庭生产率和社会参与的长期改善，包括强直性脊柱炎和非放射线性轴突性脊柱炎
3. Additional Outcomes from the First 52-Week Randomized Placebo-Controlled Study (NCT02552212) in Patients with Non-Radiographic Axial Spondyloarthritis Treated with Certolizumab Pegol [J] . Maksymowych Walter, Deodhar Atul, Gensler Lianne, The Journal of rheumatology . 2019,第7期

机译：在用Certolizumab Pegol处理的非放射线轴向脊柱膜炎患者中，来自前52周随机安慰剂对照研究（NCT02552212）的其他结果
4. Arterial Stiffness in Portuguese Patients with Axial Spondyloarthritis: a pilot study^* [C] . Beatriz Ramalho, Andreia Serrano, Paulo Bonifácio, IEEE Portuguese Meeting in Bioengineering . 2019

机译：葡萄牙轴突性脊柱关节炎患者的动脉僵硬度：一项初步研究^*
5. Extended report: Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study [O] . R Landewé, J Braun, A Deodhar, -1

机译：扩展报告：塞妥珠单抗聚乙二醇化对轴突性脊柱关节炎包括强直性脊柱炎的体征和症状的功效：一项双盲随机安慰剂对照3期研究的24周结果
6. PMS73 Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study [O] . Sieper J., Kivitz A., van Tubergen A., 2014

机译：PMS73长期维持改善的患者报告的轴索性脊椎关节炎，包括强直性脊柱炎和非放射性轴索性脊椎关节炎患者的西妥昔单抗聚乙二醇乙二醇酯的改善：快速Axspa研究的96周结果

OP0023 Four-year imaging outcomes in axial spondyloarthritis patients treated with certolizumab pegol, including patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

著录项

引文网络

相似文献

相关主题

期刊订阅